NOVABAY PHARMACEUTICALS INC

NYSE: NBY (NovaBay Pharmaceuticals, Inc.)

Kemas kini terakhir: 2 hari lalu, 2:40AM

0.732

0.02 (3.08%)

Penutupan Terdahulu 0.710
Buka 0.710
Jumlah Dagangan 586,632
Purata Dagangan (3B) 444,132
Modal Pasaran 1,997,496
Harga / Jualan (P/S) 0.160
Harga / Buku (P/B) 1.53
Julat 52 Minggu
0.660 (-9%) — 12.60 (1621%)
Tarikh Pendapatan 9 Aug 2023 - 14 Aug 2023
Margin Keuntungan 37.43%
Margin Operasi (TTM) -55.04%
EPS Cair (TTM) 24.38
Pertumbuhan Hasil Suku Tahunan (YOY) 9.90%
Jumlah Hutang/Ekuiti (D/E MRQ) 18.24%
Nisbah Semasa (MRQ) 2.95
Aliran Tunai Operasi (OCF TTM) 5.06 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -1.51 M
Pulangan Atas Aset (ROA TTM) -44.19%
Pulangan Atas Ekuiti (ROE TTM) -240.71%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Biotechnology (US) Bercampur Menaik
Biotechnology (Global) Bercampur Menaik
Stok NovaBay Pharmaceuticals, Inc. - -

AISkor Stockmoo

-0.7
Konsensus Penganalisis NA
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal 0.0
Purata -0.67

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
NBY 2 M - - 1.53
CYBN 359 M - - 2.70
NHWK 20 M - - 0.260
AGE 19 M - - 5.08
TMBR 4 M - - -
NAVB 4 M - - -

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Sektor Healthcare
Industri Biotechnology
% Dimiliki oleh Orang Dalam 0.02%
% Dimiliki oleh Institusi 24.51%

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda